Innovative Companies Diving into The Neuro Market Ahead of 2021
The Pharma Data
DECEMBER 9, 2020
Artificial intelligence holds immense promise to catalyze the development of the next generation of highly selective, orally bioavailable molecules, with reduced side effects, for the most impactful drug targets,” Feinberg said at the time of the launch. which will remain a key shareholder. SciNeuro Pharmaceuticals. in a statement. .
52 
Let's personalize your content